Published in Croat Med J on April 01, 2015
Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review. Ther Adv Psychopharmacol (2016) 0.76
Pharmacotherapy of ADHD in Slovenia: realities and perspectives. Eur Child Adolesc Psychiatry (2016) 0.75
The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry (2007) 14.02
Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet (1998) 5.34
The worldwide prevalence of ADHD: is it an American condition? World Psychiatry (2003) 5.30
European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry (2004) 3.22
Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry (2000) 2.80
Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med (2002) 2.19
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr (2012) 1.73
Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies. J Clin Psychiatry (2007) 1.66
How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample--results of the BELLA study. Eur Child Adolesc Psychiatry (2008) 1.58
A review of the economic burden of ADHD. Cost Eff Resour Alloc (2005) 1.39
Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry (2000) 1.26
Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J Clin Psychiatry (1998) 1.21
Under diagnosis of adult ADHD: cultural influences and societal burden. J Atten Disord (2012) 1.17
The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord (2010) 1.16
Barriers to the identification of children with attention deficit/hyperactivity disorder. J Child Psychol Psychiatry (2006) 0.97
Why do general practitioners not screen and intervene regarding alcohol consumption in Slovenia? A focus group study. Wien Klin Wochenschr (2010) 0.93
Identification of children at risk of Attention Deficit/Hyperactivity Disorder: a school-based intervention. Soc Psychiatry Psychiatr Epidemiol (2006) 0.91
What may stimulate general practitioners to undertake screening and brief intervention for excess alcohol consumption in Slovenia? A focus group study. J Int Med Res (2009) 0.91
Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in slovenia from 2001 to 2012: a drug use study from a national perspective. J Child Adolesc Psychopharmacol (2015) 0.89
[The influence of different diagnostic criteria and the culture on the prevalence of attention deficit hyperactivity disorder]. Rev Neurol (2011) 0.82
Prevalence, incidence, and stimulant use of attention-deficit hyperactivity disorder in Taiwan, 1996-2005: a national population-based study. Soc Psychiatry Psychiatr Epidemiol (2012) 0.80
Limitations of the study "Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults". Vaccine (2013) 1.54
The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose. Eur J Clin Pharmacol (2006) 1.00
Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in slovenia from 2001 to 2012: a drug use study from a national perspective. J Child Adolesc Psychopharmacol (2015) 0.89
MDR1 gene polymorphisms and response to acute risperidone treatment. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.82
High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients. Int J Clin Pharmacol Ther (2013) 0.80
Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423--a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity. Drug Dev Ind Pharm (2009) 0.75
The role of individual gastric emptying of pellets in the prediction of diclofenac in vivo dissolution. J Control Release (2013) 0.75
Analysis of factors influencing gastric emptying of pellets in a fed state. Expert Opin Drug Deliv (2015) 0.75
Attitudes of physicians, nurses and pharmacists concerning the development of clinical pharmacy activities in a university hospital. Acta Pharm (2014) 0.75
Mental Health in Domesticated Immigrant Population - a Systematic Review. Psychiatr Danub (2017) 0.75